Kim SH - Search Results

1

Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy.

Shin SJ, Lee HW, Kim SH, Ahn JB, Choi HJ, Cho BC, Jeung HC, Rha SY, Chung HC, Pyo JY, Roh JK. Shin SJ, et al. Among authors: kim sh. Acta Oncol. 2007;46(4):547-9. doi: 10.1080/02841860601009463. Acta Oncol. 2007. PMID: 17497323 No abstract available.

2

Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial.

Jeong J, Cho BC, Sohn JH, Choi HJ, Kim SH, Lee YJ, Jung MK, Shin SJ, Park MS, Kim SK, Chang J, Kim JH. Jeong J, et al. Among authors: kim sh, kim sk, kim jh. Lung Cancer. 2010 Oct;70(1):77-81. doi: 10.1016/j.lungcan.2010.01.006. Epub 2010 Mar 16. Lung Cancer. 2010. PMID: 20138389 Clinical Trial.

3

Phase II study of cisplatin with irinotecan as induction chemotherapy followed by chemoradiotherapy for unresectable stage III non-small cell lung cancer.

Chang H, Kim SH, Cho BC, Yoon SH, Kim HR, Lee CG, Kim JH. Chang H, et al. Among authors: kim sh, kim hr, kim jh. Anticancer Res. 2012 Aug;32(8):3515-21. Anticancer Res. 2012. PMID: 22843939 Clinical Trial.

4

Prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.

Jung M, Kim SH, Hong S, Kang YA, Kim SK, Chang J, Rha SY, Kim JH, Kim DJ, Cho BC. Jung M, et al. Among authors: kim sh, kim dj, kim sk, kim jh. Yonsei Med J. 2012 Sep;53(5):931-9. doi: 10.3349/ymj.2012.53.5.931. Yonsei Med J. 2012. Retraction in: Yonsei Med J. 2013 Jan 1;54(1):269. doi: 10.3349/ymj.2013.54.1.269 PMID: 22869475 Free PMC article. Retracted.

5

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.

Kim SH, Park KH, Shin SJ, Lee KY, Kim TI, Kim NK, Rha SY, Roh JK, Ahn JB. Kim SH, et al. Among authors: kim ti, kim nk. Cancer Res Treat. 2016 Jan;48(1):208-15. doi: 10.4143/crt.2014.314. Epub 2015 Apr 24. Cancer Res Treat. 2016. PMID: 25943321 Free PMC article.

6

The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.

Kim SH, Cho BC, Choi HJ, Chung KY, Kim DJ, Park MS, Kim SK, Chang J, Shin SJ, Sohn JH, Kim JH. Kim SH, et al. Among authors: kim dj, kim sk, kim jh. Lung Cancer. 2008 Jun;60(3):393-400. doi: 10.1016/j.lungcan.2007.11.004. Epub 2007 Dec 26. Lung Cancer. 2008. PMID: 18155802

7

A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy: a case report.

Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, Cho NH, Jeung HC. Kim SH, et al. Among authors: kim jh. Cancer Res Treat. 2007 Sep;39(3):134-7. doi: 10.4143/crt.2007.39.3.134. Epub 2007 Sep 30. Cancer Res Treat. 2007. PMID: 19746221 Free PMC article.

8

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).

Kim SH, Shim HS, Cho J, Jeong JH, Kim SM, Hong YK, Sung JH, Ha SJ, Kim HR, Chang H, Kim JH, Tania C, Cho BC. Kim SH, et al. Among authors: kim sm, kim hr, kim jh. Lung Cancer. 2013 Mar;79(3):270-5. doi: 10.1016/j.lungcan.2012.11.017. Epub 2012 Dec 20. Lung Cancer. 2013. PMID: 23261229 Clinical Trial.

9

Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib.

Jung M, Kim SH, Lee YJ, Hong S, Kang YA, Kim SK, Chang J, Rha SY, Kim JH, Kim DJ, Cho BC. Jung M, et al. Among authors: kim sh, kim dj, kim sk, kim jh. Exp Ther Med. 2011 Jul;2(4):685-693. doi: 10.3892/etm.2011.273. Epub 2011 May 12. Exp Ther Med. 2011. PMID: 22977560 Free PMC article.

10

Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.

Kim SH, Shin SJ, Lee KY, Kim H, Kim TI, Kang DR, Hur H, Min BS, Kim NK, Chung HC, Roh JK, Ahn JB. Kim SH, et al. Among authors: kim h, kim ti, kim nk. Ann Surg Oncol. 2013 Oct;20(11):3407-13. doi: 10.1245/s10434-013-3169-1. Epub 2013 Aug 14. Ann Surg Oncol. 2013. PMID: 23943026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,142 results

Search Page

Filters